HOME Study
As part of the National Eye Institute-sponsored AREDS2 study, the HOME study showed 94% of patients using ForeseeHome who progressed to wet AMD maintained 20/40 or better vision compared to only 62% of patients whose diagnosis was at a routine eye exam or a visit triggered by symptoms. The Data and Safety Monitoring Committee recommended early study termination for efficacy.